Alvotech announces positive top-line results from a pharmacokinetic study for avt05, a proposed biosimilar for simponi® and simponi aria®

The study, assessing pharmacokinetics, safety, and tolerability of avt05 compared to simponi® (golimumab) in healthy adult subjects, met its primary endpoint the study, assessing pharmacokinetics, safety, and tolerability of avt05 compared to simponi® (golimumab) in healthy adult subjects, met its primary endpoint
ALVO Ratings Summary
ALVO Quant Ranking